IRIS
ROTI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.207
AS - Asia 3.655
EU - Europa 3.177
SA - Sud America 606
AF - Africa 199
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.854
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.085
SG - Singapore 1.559
CN - Cina 1.134
IT - Italia 932
IE - Irlanda 490
BR - Brasile 481
SE - Svezia 359
HK - Hong Kong 353
DE - Germania 330
VN - Vietnam 230
FI - Finlandia 187
NL - Olanda 179
UA - Ucraina 148
ZA - Sudafrica 129
FR - Francia 105
GB - Regno Unito 101
RU - Federazione Russa 101
AT - Austria 100
TR - Turchia 94
CA - Canada 71
IN - India 69
AR - Argentina 50
BD - Bangladesh 48
MX - Messico 33
CI - Costa d'Avorio 31
JP - Giappone 29
PL - Polonia 29
BE - Belgio 24
IQ - Iraq 24
EC - Ecuador 22
KR - Corea 22
CZ - Repubblica Ceca 16
ID - Indonesia 16
CO - Colombia 15
ES - Italia 15
LT - Lituania 13
IR - Iran 12
PY - Paraguay 10
PK - Pakistan 9
VE - Venezuela 9
UZ - Uzbekistan 8
AU - Australia 7
CL - Cile 7
EG - Egitto 7
DZ - Algeria 6
JM - Giamaica 6
KE - Kenya 6
MA - Marocco 6
PA - Panama 6
RO - Romania 6
TN - Tunisia 6
UY - Uruguay 6
AZ - Azerbaigian 5
CH - Svizzera 5
IL - Israele 5
LU - Lussemburgo 5
BG - Bulgaria 4
ET - Etiopia 4
HU - Ungheria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NP - Nepal 4
PE - Perù 4
AL - Albania 3
DO - Repubblica Dominicana 3
GR - Grecia 3
HR - Croazia 3
LB - Libano 3
OM - Oman 3
PH - Filippine 3
RS - Serbia 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
BH - Bahrain 2
JO - Giordania 2
KH - Cambogia 2
MD - Moldavia 2
MY - Malesia 2
NO - Norvegia 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CD - Congo 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GP - Guadalupe 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MT - Malta 1
NG - Nigeria 1
NR - Nauru 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
Totale 11.853
Salva come PNG Salva come JPEG
Città #
Singapore 797
Ashburn 613
Dublin 490
Chandler 472
Dallas 470
Hong Kong 349
Beijing 279
Parma 274
Santa Clara 263
Boardman 190
Jacksonville 135
Ann Arbor 126
Johannesburg 123
Dearborn 105
Munich 99
Los Angeles 91
Princeton 90
Nanjing 85
Vienna 85
Ho Chi Minh City 83
New York 81
Shanghai 79
Izmir 72
Hefei 70
Bologna 62
Milan 62
Wilmington 62
Helsinki 55
Grafing 53
Shenyang 51
San Mateo 50
Hanoi 49
São Paulo 49
Marseille 48
Jinan 44
Nanchang 43
Moscow 42
Columbus 37
Buffalo 35
Toronto 34
Hebei 32
Turku 32
Abidjan 31
Seattle 31
Rome 28
Amsterdam 26
Guangzhou 26
Changsha 25
Tianjin 25
Modena 24
Verona 24
Nuremberg 23
The Dalles 23
Chicago 22
Kunming 22
Montreal 22
Reggio Emilia 22
Seoul 22
Brussels 21
Des Moines 21
Tokyo 21
Rio de Janeiro 20
Warsaw 20
Frankfurt am Main 19
Pune 19
Bremen 17
Brooklyn 17
Brescia 16
Fremont 16
Houston 16
Jiaxing 16
London 16
Da Nang 15
Denver 15
Phoenix 15
West Jordan 14
Atlanta 13
Jakarta 13
Norwalk 13
Perugia 13
Poplar 13
Zhengzhou 13
Brasília 12
Brno 12
Düsseldorf 12
Haiphong 12
San Francisco 12
Belo Horizonte 11
Bengaluru 11
Quattro Castella 11
Woodbridge 11
Chongqing 10
Council Bluffs 10
Florence 10
Hangzhou 10
Manchester 10
Mexico City 10
Quito 10
Carpi 9
Haikou 9
Totale 7.341
Salva come PNG Salva come JPEG
Nome #
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 213
Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell line 192
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 180
1328P Dynamic blood immune-inflammatory and radiomic profiling to decode distinct patterns of acquired resistance to immunotherapy in NSCLC patients 175
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors 172
227P Sexual dimorphism in immune profile of early and advanced NSCLC 170
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 168
Targeting oncogenic Notch signaling with SERCA inhibitors 164
Impact of the rs1024611 polymorphism of ccl2 on the pathophysiology and outcome of primary myelofibrosis 158
Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia 157
Morphological, clinical, and molecular profiling of post-polycythemia vera accelerated/blast phase occurring with and without antecedent secondary myelofibrosis 155
189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC 145
Bone marrow endothelial cells carry bcr/abl fusion gene from chronic myeloid leukemia patients 142
LONGITUDINAL MONITORING OF RADIOMIC AND BLOOD IMMUNE-INFLAMMATORY DESCRIPTORS AS A NON-INVASIVE APPROACH TO PREDICT ICI EFFICACY IN ADVANCED NSCLC PATIENTS 136
17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients 136
Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 133
Bone marrow endothelial cells carry bcr/abl fusion gene from chronic myeloid leukemia patients 133
Bone marrow endothelial cells carry bcr/abl fusion gene from chronic myeloid leukemia patients 133
Angiopoietins expression by human myeloma cells 132
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 130
IL-7 is induced by IL-6 in human myeloma cells: role in multiple myeloma 129
Pro-angiogenetic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 129
Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testes 126
2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients 125
Human myeloma cells produce angiopoietin-1 but not angiopoietin-2: potential relationship with myeloma-induced angiogenesis 125
BCR/ABL fusion gene is detected in chronic myeloid leukemia endothelial cells 124
Acute lymphoblastic leukaemia in Noonan syndrome. 116
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 116
Targeting Notch Trafficking and Processing in Cancers 116
Identification of the Atypical Protein Kinase WNK1 As a New Target in T-Cell Acute Lymphoblastic Leukemia 115
BCR/ABL fusion gene is detected in chronic myeloid leukemia endothelial cells 111
Down-Modulation of Erk Protein Kinase Activity Inhibits Vascular Endothelial Growth Factor (VEGF) Secretion by human Myeloma Cell Lines 109
Longitudinal Changes of CT-radiomic and Systemic Inflammatory Features Predict Survival in Advanced Non–Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors 106
Activating somatic and germline TERT promoter variants in myeloid malignancies 106
THERAPEUTIC TARGETING OF NOTCH SIGNALING PATHWAY IN HEMATOLOGICAL MALIGNANCIES 106
VASCULAR ENDOTHELIAL GROWTH FACTOR SECRETION BY MYELOMA CELLS IS INHIBITED BY DOWN-MODULATING ERK PROTEIN KINASE ACTIVITY 105
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 105
Venetoclax and bortezomib in relapsed/refractory early t-cell precursor acute lymphoblastic leukemia 105
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML 105
Osteopontin is produced by human multiple myeloma cells 104
IL-7 is produced by myeloma cells in presence of IL-6 104
Multiple myeloma patient with unusual extramedullary involvement 104
14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia 104
Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia 103
SERCA MODULATION COUNTERACTS GLUCOCORTICOID RESISTANCE IN T-ALL 102
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders 101
1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC 101
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 101
MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia 101
Chemical Genomic Screen Identifies Ionophores as Modulators of Notch1 in T-ALL 98
Haploidentical hematopoietic stem cell transplantation in adults using the αβTCR/CD19-based depletion of G-CSF-mobilized peripheral blood progenitor cells 97
P1.15-04 Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 96
Down-modulation of ERK protein kinase activity suppresses human myeloma cell proliferation and myeloma-induced angiogenesis by VEGF inhibition 96
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro 94
The Atypical Protein Kinase WNK1 Controls Leukemia Progression in TAL/LMO T-Cell Acute Lymphoblastic Leukemia 94
Acute lymphoblastic leukaemia 94
Paracrine rather than autocrine basic FGF (bFGF) loop in multiple myeloma 94
Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling 94
Multiple Myeloma patient with unusual extramedullary involvement 93
Multiple myeloma patient with unusual extramedullary involvement 93
Down-modulation of ERK protein kinase activity inhibits vascular endothelial growth factor (VEGF) secretion by human myeloma cell lines 92
SELECTIVE BLOCKADE OF ONCOGENIC NOTCH1 WITH THE NEW SERCA INHIBITOR CAD204520 89
A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan Syndrome 89
Synergistic drug combinations with a CDK4/6 inhibitor in T-cell acute lymphoblastic leukemia 89
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 89
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 88
Human myeloma cells express IL-7 mRNA and secrete IL-7 in presence of IL-6 88
Paracrine rather than autocrine basic FGF (bFGF) loop in multiple myeloma 88
Genetic and proteomic approaches to identify cancer drug targets. 88
Bone marrow endothelial cells carry BCR/ABL fusion gene from chronic myeloid leukemia patients. 88
WO/2016/073708 88
Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia 87
Bilateral tonsillar infiltration of T-cell prolymphocytic leukemia 87
Cryptic chromosome 9q34 deletion generates TAF-Ialpha/CAN and TAF-Ibeta/CAN fusion transcripts in acute myeloid leukemia. 86
A distinct epigenetic program underlies the 1;7 translocation in myelodysplastic syndromes 86
Design of a Comprehensive Fluorescence in Situ Hybridization Assay for Genetic Classification of T-Cell Acute Lymphoblastic Leukemia 86
Leukemia-specific delivery of mutant NOT CH1 targeted therapy 85
Nivolumab-Induced Guillain-Barré Syndrome Coupled With Remarkable Disease Response in a Case of Heavily Pretreated Lung Adenocarcinoma 85
IL-7 is produced by myeloma cells in presence of IL-6 85
Selective Blockade of Oncogenic NOTCH1 with the New SERCA Inhibitor CAD204520 in T-cell Acute Lymphoblastic Leukemia 82
Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC 82
Genetics of Darier’s Disease: New Insights into Pathogenic Mechanisms 81
Genetic profile of acute lymphoblastic leukemia in a patient with the noonan syndrome 81
Complementary genomic screens identify SERCA as a therapeutic target in NOTCH1 mutated cancer. 78
Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors. 78
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 76
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: From current standards to precision medicine 75
Differentially regulated high-throughput CT imaging features correlate to distinct tumor immune contextures portraying a radiomic signature with prognostic impact on surgically resected NSCLC 75
Down-modulation of ERK protein kinase activity inhibits vascular endothelial growth factor (VEGF) secretion by human myeloma cell lines. 74
Lenvatinib Targets PDGFR-β Pericytes and Inhibits Synergy with Thyroid Carcinoma Cells: Novel Translational Insights 74
e6a2 BCR/ABL1 fusion with cryptic der(9)t(9;22) deletions in a patient with chronic myeloid leukemia 73
Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia. 72
Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin 70
Constitutive phosphorylation of Janus kinase2 in the GL15 glioblastoma derived human cell line 69
T(10;11)(P13;P14-21) PICALM-MLLT10 ACUTE LEUKEMIA: CHARACTERIZATION OF TWO CASES WITH DIFFERENT PHENOTYPIC PRESENTATION 68
New somatic TERT promoter variants enhance the Telomerase activity in Glioblastoma 68
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma 67
Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E 67
FROM GENOMICS TO CHEMOGEGNOMICS IN T CELL ACUTE LYMPHOBLASTIC LEUKEMIA 65
DHPLC analysis of NPM1 mutations in adult primary AML. 64
Totale 10.573
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.446
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021352 0 0 0 0 0 17 34 23 128 47 78 25
2021/2022517 16 16 11 15 7 64 72 55 27 40 32 162
2022/20231.922 219 191 106 124 206 206 32 117 585 7 82 47
2023/2024987 50 64 29 41 85 184 124 80 40 72 72 146
2024/20253.056 90 164 215 235 337 246 145 137 350 251 275 611
2025/20263.809 582 537 1.006 669 936 79 0 0 0 0 0 0
Totale 12.052